BCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Brinks Co (BCO) is a good buy for a beginner investor with a long-term horizon and $50,000-$100,000 available for investment. The company's strong financial performance, positive analyst ratings, and growth potential from its recent acquisition outweigh the short-term technical weakness and insider selling. Despite no proprietary trading signals today, the stock's fundamentals and growth trajectory make it a solid long-term investment.
The technical indicators suggest a bearish trend in the short term. The MACD histogram is negative and contracting, the RSI is neutral at 36.371, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 102.737, with support at 97.842 and resistance at 107.633. However, these technical signals are less relevant for long-term investors.
Strong Q4 financial performance with revenue up 9.08% YoY and EPS up 87.36% YoY.
Positive analyst sentiment with raised price targets (Goldman Sachs: $145, Truist: $
and Buy ratings.
High-growth segments like Digital Retail Solutions and ATM Managed Services showing 22% organic growth.
Acquisition of NCR Atleos Corporation expected to deliver $200M in annual run-rate synergies within three years.
Insider selling has increased significantly by 6155.86% over the last month.
The broader market sentiment is negative, with the S&P 500 down 1.79%.
Short-term technical indicators are bearish, suggesting potential near-term price weakness.
In Q4 2025, Brinks reported revenue of $1.379 billion, up 9.08% YoY. Net income increased by 76.88% YoY to $68.1 million, and EPS rose by 87.36% YoY to 1.63. Gross margin improved to 27.73%, up 6.33% YoY. These results demonstrate strong growth and profitability.
Analysts are bullish on BCO. Goldman Sachs raised its price target to $145, citing strong Q4 results and growth potential from the NCR Atleos acquisition. Truist raised its price target to $163, highlighting a 13% segment revenue CAGR and 12% free cash flow CAGR through FY30. Both firms maintain Buy ratings.
